Treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trial

The Lancet Infectious Diseases

Volumn 18, Issue 8, 2018, Pages 854-863

  Wolf, Joshua ^a,b,c   Connell, Tom G ^c,d   Allison, Kim J ^a   Tang, Li ^a   Richardson, Julie ^a   Branum, Kristen ^a   Borello, Eloise ^d   Rubnitz, Jeffrey E ^a,b   Gaur, Aditya H ^a,b   Hakim, Hana ^a   Su, Yin ^a   Federico, Sara M ^a   Mechinaud, Francoise ^d   Hayden, Randall T ^a   Monagle, Paul ^c,d   Worth, Leon J ^c,e,f   Curtis, Nigel ^c,d   Flynn, Patricia M ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e PETER MACCALLUM CANCER CENTRE   (Australia)

^f PETER DOHERTY INSTITUTE FOR INFECTION AND IMMUNITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; FIBRINOLYTIC AGENT; TOPICAL ANTIINFECTIVE AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CATHETER INFECTION; CATHETER OCCLUSION; CATHETER REMOVAL; CHILD; CHILDHOOD CANCER; CONFUSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; DYSGEUSIA; ETHANOL LOCK THERAPY; FEMALE; FIBRINOLYTIC THERAPY; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HICCUP; HUMAN; INFECTION PREVENTION; INFUSION RELATED REACTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PEDIATRIC HOSPITAL; PERSISTENT INFECTION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS; SCHOOL CHILD; SIDE EFFECT; SUPERIORITY TRIAL; THORAX PAIN; TREATMENT DURATION; URTICARIA; ADOLESCENT; ADVERSE DEVICE EFFECT; AUSTRALIA; BACTEREMIA; CENTRAL VENOUS CATHETERIZATION; INDWELLING CATHETER; INFANT; NEOPLASM; PRESCHOOL CHILD; SECONDARY PREVENTION; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ANTI-INFECTIVE AGENTS, LOCAL; AUSTRALIA; BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; ETHANOL; FEMALE; HUMANS; INFANT; MALE; NEOPLASMS; SECONDARY PREVENTION; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 85048588366     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(18)30224-X     Document Type: Article

References (31)

1. Wilson, MZ, Rafferty, C, Deeter, D, Comito, MA, Hollenbeak, CS, Attributable costs of central line-associated bloodstream infections in a pediatric hematology/oncology population. Am J Infect Control 42 (2014), 1157–1160.
2. Wolf, J, Shenep, JL, Clifford, V, Curtis, N, Flynn, PM, Ethanol lock therapy in pediatric hematology and oncology. Pediatr Blood Cancer 60 (2013), 18–25.
3. Mermel, LA, Allon, M, Bouza, E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49 (2009), 1–45.
4. Wolf, J, Curtis, N, Worth, LJ, Flynn, PM, Central line-associated bloodstream infection in children: an update on treatment. Pediatr Infect Dis J 32 (2013), 905–910.
5. Flynn, PM, Willis, B, Gaur, AH, Shenep, JL, Catheter design influences recurrence of catheter-related bloodstream infection in children with cancer. J Clin Oncol 21 (2003), 3520–3525.
6. Donlan, RM, Costerton, JW, Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15 (2002), 167–193.
7. Norris, LB, Kablaoui, F, Brilhart, MK, Bookstaver, PB, Systematic review of antimicrobial lock therapy for prevention of central-line-associated bloodstream infections in adult and pediatric cancer patients. Int J Antimicrob Agents 50 (2017), 308–317.
8. Shenep, LE, Shenep, MA, Cheatham, W, et al. Efficacy of intravascular catheter lock solutions containing preservatives in the prevention of microbial colonization. J Hosp Infect 79 (2011), 317–322.
9. Schoot, RA, van Ommen, CH, Stijnen, T, et al. Prevention of central venous catheter-associated bloodstream infections in paediatric oncology patients using 70% ethanol locks: a randomised controlled multi-centre trial. Eur J Cancer 51 (2015), 2031–2038.
10. Mermel, LA, Alang, N, Adverse effects associated with ethanol catheter lock solutions: a systematic review. J Antimicrob Chemother 69 (2014), 2611–2619.
11. US Centers for Disease Control and Prevention. Bloodstream infection event (central line-associated bloodstream infection and non-central line-associated bloodstream infection). http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf, January, 2018. (Accessed 24 May 2018)
12. Gaur, AH, Bundy, DG, Werner, EJ, et al. A prospective, holistic, multicenter approach to tracking and understanding bloodstream infections in pediatric hematology-oncology patients. Infect Control Hosp Epidemiol 38 (2017), 690–696.
13. Zelen, M, Randomization and stratification of patients to clinical trials. J Chronic Dis 27 (1974), 365–375.
14. Atkinson, MJ, Kumar, R, Cappelleri, JC, Hass, SL, Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health 8:suppl 1 (2005), S9–S24.
15. Allen, RC, Holdsworth, MT, Johnson, CA, et al. Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer 51 (2008), 53–58.
16. Lan, KKG, DeMets, DL, Discrete sequential boundaries for clinical-trials. Biometrika 70 (1983), 659–663.
17. Jennison, C, Turnbull, BW, Group sequential methods with applications to clinical trials. 2000, Chapman and Hall/CRC, London.
18. Gaur, AH, Flynn, PM, Heine, DJ, Giannini, MA, Shenep, JL, Hayden, RT, Diagnosis of catheter-related bloodstream infections among pediatric oncology patients lacking a peripheral culture, using differential time to detection. Pediatr Infect Dis J 24 (2005), 445–449.
19. American Academy of Pediatrics Committee on Drugs. Ethanol in liquid preparations intended for children. Pediatrics 73 (1984), 405–407.
20. Khosroshahi, HT, Mahdipur, H, Parkhideh, S, Basmenji, S, Khalilzadeh, M, Tozihi, M, The effectiveness of systemic antibiotic therapy with and without ethanol-locked solution in the treatment of hemodialysis-related catheter infection. Saudi J Kidney Dis Transpl 26 (2015), 477–481.
21. O'Horo, JC, Silva, GL, Safdar, N, Anti-infective locks for treatment of central line-associated bloodstream infection: a systematic review and meta-analysis. Am J Nephrol 34 (2011), 415–422.
22. Wolf, J, Allison, KJ, Tang, L, Sun, Y, Hayden, RT, Flynn, PM, No evidence of benefit from antibiotic lock therapy in pediatric oncology patients with central line–related bloodstream infection: results of a retrospective matched cohort study and review of the literature. Pediatr Blood Cancer 61 (2014), 1811–1815.
23. Ardura, MI, Lewis, J, Tansmore, JL, Harp, PL, Dienhart, MC, Balint, JP, Central catheter-associated bloodstream infection reduction with ethanol lock prophylaxis in pediatric intestinal failure: broadening quality improvement initiatives from hospital to home. JAMA Pediatr 169 (2015), 324–331.
24. Sanders, J, Pithie, A, Ganly, P, et al. A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. J Antimicrob Chemother 62 (2008), 809–815.
25. Slobbe, L, Doorduijn, JK, Lugtenburg, PJ, et al. Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial. PLoS One, 5, 2010, e10840.
26. Luther, MK, Bilida, S, Mermel, LA, LaPlante, KL, Ethanol and isopropyl alcohol exposure increases biofilm formation in Staphylococcus aureus and Staphylococcus epidermidis. Infect Dis Ther 4 (2015), 219–226.
27. Schilcher, G, Schlagenhauf, A, Schneditz, D, et al. Ethanol causes protein precipitation–new safety issues for catheter locking techniques. PLoS One, 8, 2013, e84869.
28. Journeycake, JM, Buchanan, GR, Catheter-related deep venous thrombosis and other catheter complications in children with cancer. J Clin Oncol 24 (2006), 4575–4580.
29. Spencer, TR, Mahoney, KJ, Reducing catheter-related thrombosis using a risk reduction tool centered on catheter to vessel ratio. J Thromb Thrombolysis 44 (2017), 427–434.
30. Chopra, V, Kaatz, S, Conlon, A, et al. The Michigan Risk Score to predict peripherally inserted central catheter-associated thrombosis. J Thromb Haemost 15 (2017), 1951–1962.
31. Chaftari, AM, Jordan, M, Hachem, R, et al. A clinical practical approach to the surveillance definition of central line-associated bloodstream infection in cancer patients with mucosal barrier injury. Am J Infect Control 44 (2016), 931–934.